These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Availability of antidotes at acute care hospitals in Ontario. Juurlink DN; McGuigan MA; Paton TW; Redelmeier DA CMAJ; 2001 Jul; 165(1):27-30. PubMed ID: 11468950 [TBL] [Abstract][Full Text] [Related]
3. A cost comparison of Canadian and U.S. hospital pharmacy departments. Weil TP Hosp Pharm; 1994 Jan; 29(1):15-7, 20-3. PubMed ID: 10131492 [TBL] [Abstract][Full Text] [Related]
4. Antidote availability in Quebec hospital pharmacies: impact of N-acetylcysteine and naloxone consumption. Bailey B; Bussières JF Can J Clin Pharmacol; 2000; 7(4):198-204. PubMed ID: 11118966 [TBL] [Abstract][Full Text] [Related]
5. [Antidote availability in Norway]. Solheim L; Andrew E; Jacobsen D Tidsskr Nor Laegeforen; 2002 Apr; 122(11):1111-3. PubMed ID: 12043055 [TBL] [Abstract][Full Text] [Related]
6. One hospital's success with medication budget control. McLean W; Simon V Leadersh Health Serv; 1994; 3(2):6-10. PubMed ID: 10133642 [TBL] [Abstract][Full Text] [Related]
7. [Hospital essential drugs in Africa. An example of pharmacoeconomic research]. Meillon C; Stum N; Cuisinier-Raynal JC Dakar Med; 1996; Spec No():19-20. PubMed ID: 14520980 [No Abstract] [Full Text] [Related]
8. Availability of antidotes in Quebec hospitals before and after dissemination of guidelines. Bailey B; Bussières JF; Dumont M Am J Health Syst Pharm; 2003 Nov; 60(22):2345-9. PubMed ID: 14652984 [No Abstract] [Full Text] [Related]
9. How pharmaceutical controls worked in one Ontario hospital. McLean WM; Tierney MG Can J Hosp Pharm; 1994 Aug; 47(4):176-9. PubMed ID: 10136951 [No Abstract] [Full Text] [Related]
10. Use of the EOQ formula in hospital pharmacy purchasing. Lamson MJ; Mahoney CD; Jeffrey LP Am J Hosp Pharm; 1982 Nov; 39(11):1852, 1854. PubMed ID: 7148848 [No Abstract] [Full Text] [Related]
11. Improving budget control: a case study. Karali J Hosp Cost Manag Account; 1993 May; 5(2):1-8. PubMed ID: 10125473 [No Abstract] [Full Text] [Related]
12. A pharmacoeconomic analysis of IV H2-receptor antagonist use in 40 hospitals. Segal R; Oh T; Ben-Joseph R; Russell WL Hosp Formul; 1994 May; 29(5):379-82, 388-91. PubMed ID: 10136601 [TBL] [Abstract][Full Text] [Related]
13. Availability of pralidoxime and implications of inadequate stocking. Burda AM; Uthaivongsakdi KT; Sigg T; Wahl M Am J Health Syst Pharm; 2004 Jul; 61(13):1336-7. PubMed ID: 15287224 [No Abstract] [Full Text] [Related]
14. Availability of antidotes in rural and urban hospitals in Tennessee. Chyka PA; Conner HG Am J Hosp Pharm; 1994 May; 51(10):1346-8. PubMed ID: 8085575 [No Abstract] [Full Text] [Related]
15. Pharmacy non-salary expenses per admission. Napier A; Holzman MS Hosp Mater Manage; 1992 Sep; 17(9):10-1. PubMed ID: 10121468 [No Abstract] [Full Text] [Related]
16. Pharmacy inventory management (PIM) strategy. Sok JE Top Hosp Pharm Manage; 1985 Feb; 4(4):33-44. PubMed ID: 10314106 [No Abstract] [Full Text] [Related]
17. [Availability of antidotes in hospital pharmacies in the Czech Republic]. Hrubý K Ceska Slov Farm; 2003 Sep; 52(5):231-40. PubMed ID: 14619700 [TBL] [Abstract][Full Text] [Related]